The study authors note there is an urgent need for "innovative value-based and alternative payment models of care."
|Articles|April 10, 2012
Insurers Dodged Billions in Rebate Payments
Advertisement
If the Affordable Care Act's requirement that insurers spend at least 80% on patient care had come into effect a year early, policyholders would have received about $2 billion in rebates from insurance companies, according to a new report from the Commonwealth Fund.
The medical loss ratio (MLR) provision of the Affordable Care Act (ACA) mandates that starting in 2011, insurers covering large groups must spend at least 85 cents per dollar of revenue on medical care or "activities that improve healthcare quality." For small group and individual plans, they must spend 80 cents per dollar.
Read the full story:
Source: MedPage Today
Advertisement
Related to this article
A legal fight over a single amino acid could set retatrutide's exclusivity window, its Medicare negotiation clock, and its competitive future.
Build scalable obesity care with multidisciplinary teams, clear triage, and monitoring protocols; address GLP-1 gaps, Medicare access and price barriers, including oral GLP-1.
The FDA approves atezolizumab with a fluoropyrimidine and oxaliplatin as adjuvant therapy for stage III dMMR colon cancer based on the ATOMIC trial.
Washington, DC, clinicians shared how order sets, pharmacist-led dosing, and better handoffs can close iron deficiency gaps in heart failure care.
The conference, held in New Orleans, Louisiana, by the American Academy of Ophthalmology, will offer 3 full days of content spanning from glaucoma to dry eye.
A JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know if Retatrutide Is Classified as a Biologic
2
FDA Approves First Symptomatic Dermographism Treatment
3
Sacral Neuromodulation Still Seen as OAB Gold Standard in Review
4
Predoc and Nebraska Cancer Specialists: Not Letting the Fax Be the Fumble
5